| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.008 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.095 | 0.009 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.009 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |